BioMark Expands Its Liquid Biopsy Platform with Two Groundbreaking Publications in Breast Cancer Detection
BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection. Vancouver, British Columbia--(Newsfile Corp. - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE ...
Fred Hutch1d
New funding drives slate of breast cancer studies
Six/UW/Seattle Children’s Cancer Consortium scientists received new funding from the Breast Cancer Research Foundation to ...
Midland Daily News2d
MyMichigan Health: Lung cancer screening: beating odds and improving life
Each year, approximately 200,000 Americans will be diagnosed with lung cancer and nearly 5,000 deaths will occur annually in ...
bmjopensem.bmj2d
Cardiac health in breast cancer (CHiB): protocol for a single-centre, randomised controlled trial
The incidence of breast cancer has increased from 900 000 to 2.3 million new annual cases over the last 25 years. The 5-year ...
mskcc.org4d
Questions to Ask If You've Been Diagnosed With Lung Cancer
Learn about the questions to ask a lung cancer doctor after being diagnosed, from an MSK specialist who has successfully ...
Promising Results from Atossa Therapeutics’ I-SPY 2 Study Lead to Buy Rating for Z-endoxifen in Breast Cancer Treatment
Emily Bodnar, an analyst from H.C. Wainwright, maintained the Buy rating on Atossa Therapeutics (ATOS – Research Report). The associated ...
UK Markey Cancer Center pursues cutting-edge research. Could gold play a role?
Across the country, one of every eight women will receive a breast cancer diagnosis in their lifetime. Kentucky’s diagnosis ...
Targeted Oncology7d
AI Outperforms Standard HRD Tests for Breast, Ovarian Cancers
DeepHRD predicted homologous recombination deficiency with greater accuracy than FDA-approved standard molecular tests.